Cargando…

Two oxytocin analogs, N-(p-fluorobenzyl) glycine and N-(3-hydroxypropyl) glycine, induce uterine contractions ex vivo in ways that differ from that of oxytocin

Contraction of the uterus is critical for parturient processes. Insufficient uterine tone, resulting in atony, can potentiate postpartum hemorrhage; thus, it is a major risk factor and is the main cause of maternity-related deaths worldwide. Oxytocin (OT) is recommended for use in combination with o...

Descripción completa

Detalles Bibliográficos
Autores principales: Cherepanov, Stanislav M., Yuhi, Teruko, Iizuka, Takashi, Hosono, Takashi, Ono, Masanori, Fujiwara, Hiroshi, Yokoyama, Shigeru, Shuto, Satoshi, Higashida, Haruhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910740/
https://www.ncbi.nlm.nih.gov/pubmed/36758056
http://dx.doi.org/10.1371/journal.pone.0281363
_version_ 1784884849557897216
author Cherepanov, Stanislav M.
Yuhi, Teruko
Iizuka, Takashi
Hosono, Takashi
Ono, Masanori
Fujiwara, Hiroshi
Yokoyama, Shigeru
Shuto, Satoshi
Higashida, Haruhiro
author_facet Cherepanov, Stanislav M.
Yuhi, Teruko
Iizuka, Takashi
Hosono, Takashi
Ono, Masanori
Fujiwara, Hiroshi
Yokoyama, Shigeru
Shuto, Satoshi
Higashida, Haruhiro
author_sort Cherepanov, Stanislav M.
collection PubMed
description Contraction of the uterus is critical for parturient processes. Insufficient uterine tone, resulting in atony, can potentiate postpartum hemorrhage; thus, it is a major risk factor and is the main cause of maternity-related deaths worldwide. Oxytocin (OT) is recommended for use in combination with other uterotonics for cases of refractory uterine atony. However, as the effect of OT dose on uterine contraction and control of blood loss during cesarean delivery for labor arrest are highly associated with side effects, small amounts of uterotonics may be used to elicit rapid and superior uterine contraction. We have previously synthesized OT analogs 2 and 5, prolines at the 7(th) positions of which were replaced with N-(p-fluorobenzyl) glycine [thus, compound 2 is now called fluorobenzyl (FBOT)] or N-(3-hydroxypropyl) glycine [compound 5 is now called hydroxypropyl (HPOT)], which exhibited highly potent binding affinities for human OT receptors in vitro. In this study, we measured the ex vivo effects of FBOT and HPOT on contractions of uteri isolated from human cesarean delivery samples and virgin female mice. We evaluated the potency and efficacy of the analogs on uterine contraction, additivity with OT, and the ability to overcome the effects of atosiban, an OT antagonist. In human samples, the potency rank judged by the calculated EC(50) (pM) was as follows: HPOT (189) > FBOT (556) > OT (5,340) > carbetocin (12,090). The calculated Emax was 86% for FBOT and 75% for HPOT (100%). Recovery from atosiban inhibition after HPOT treatment was as potent as that after OT treatment. HPOT showed additivity with OT. FBOT (56 pM) was found to be the strongest agonist in virgin mouse uterus. HPOT and FBOT demonstrated high potency and partial agonist efficacy in the human uterus. These results suggested that HPOT and FBOT are highly uterotonic for the human uterus and performed better than OT, indicating that they may prevent postpartum hemorrhage.
format Online
Article
Text
id pubmed-9910740
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-99107402023-02-10 Two oxytocin analogs, N-(p-fluorobenzyl) glycine and N-(3-hydroxypropyl) glycine, induce uterine contractions ex vivo in ways that differ from that of oxytocin Cherepanov, Stanislav M. Yuhi, Teruko Iizuka, Takashi Hosono, Takashi Ono, Masanori Fujiwara, Hiroshi Yokoyama, Shigeru Shuto, Satoshi Higashida, Haruhiro PLoS One Research Article Contraction of the uterus is critical for parturient processes. Insufficient uterine tone, resulting in atony, can potentiate postpartum hemorrhage; thus, it is a major risk factor and is the main cause of maternity-related deaths worldwide. Oxytocin (OT) is recommended for use in combination with other uterotonics for cases of refractory uterine atony. However, as the effect of OT dose on uterine contraction and control of blood loss during cesarean delivery for labor arrest are highly associated with side effects, small amounts of uterotonics may be used to elicit rapid and superior uterine contraction. We have previously synthesized OT analogs 2 and 5, prolines at the 7(th) positions of which were replaced with N-(p-fluorobenzyl) glycine [thus, compound 2 is now called fluorobenzyl (FBOT)] or N-(3-hydroxypropyl) glycine [compound 5 is now called hydroxypropyl (HPOT)], which exhibited highly potent binding affinities for human OT receptors in vitro. In this study, we measured the ex vivo effects of FBOT and HPOT on contractions of uteri isolated from human cesarean delivery samples and virgin female mice. We evaluated the potency and efficacy of the analogs on uterine contraction, additivity with OT, and the ability to overcome the effects of atosiban, an OT antagonist. In human samples, the potency rank judged by the calculated EC(50) (pM) was as follows: HPOT (189) > FBOT (556) > OT (5,340) > carbetocin (12,090). The calculated Emax was 86% for FBOT and 75% for HPOT (100%). Recovery from atosiban inhibition after HPOT treatment was as potent as that after OT treatment. HPOT showed additivity with OT. FBOT (56 pM) was found to be the strongest agonist in virgin mouse uterus. HPOT and FBOT demonstrated high potency and partial agonist efficacy in the human uterus. These results suggested that HPOT and FBOT are highly uterotonic for the human uterus and performed better than OT, indicating that they may prevent postpartum hemorrhage. Public Library of Science 2023-02-09 /pmc/articles/PMC9910740/ /pubmed/36758056 http://dx.doi.org/10.1371/journal.pone.0281363 Text en © 2023 Cherepanov et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Cherepanov, Stanislav M.
Yuhi, Teruko
Iizuka, Takashi
Hosono, Takashi
Ono, Masanori
Fujiwara, Hiroshi
Yokoyama, Shigeru
Shuto, Satoshi
Higashida, Haruhiro
Two oxytocin analogs, N-(p-fluorobenzyl) glycine and N-(3-hydroxypropyl) glycine, induce uterine contractions ex vivo in ways that differ from that of oxytocin
title Two oxytocin analogs, N-(p-fluorobenzyl) glycine and N-(3-hydroxypropyl) glycine, induce uterine contractions ex vivo in ways that differ from that of oxytocin
title_full Two oxytocin analogs, N-(p-fluorobenzyl) glycine and N-(3-hydroxypropyl) glycine, induce uterine contractions ex vivo in ways that differ from that of oxytocin
title_fullStr Two oxytocin analogs, N-(p-fluorobenzyl) glycine and N-(3-hydroxypropyl) glycine, induce uterine contractions ex vivo in ways that differ from that of oxytocin
title_full_unstemmed Two oxytocin analogs, N-(p-fluorobenzyl) glycine and N-(3-hydroxypropyl) glycine, induce uterine contractions ex vivo in ways that differ from that of oxytocin
title_short Two oxytocin analogs, N-(p-fluorobenzyl) glycine and N-(3-hydroxypropyl) glycine, induce uterine contractions ex vivo in ways that differ from that of oxytocin
title_sort two oxytocin analogs, n-(p-fluorobenzyl) glycine and n-(3-hydroxypropyl) glycine, induce uterine contractions ex vivo in ways that differ from that of oxytocin
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910740/
https://www.ncbi.nlm.nih.gov/pubmed/36758056
http://dx.doi.org/10.1371/journal.pone.0281363
work_keys_str_mv AT cherepanovstanislavm twooxytocinanalogsnpfluorobenzylglycineandn3hydroxypropylglycineinduceuterinecontractionsexvivoinwaysthatdifferfromthatofoxytocin
AT yuhiteruko twooxytocinanalogsnpfluorobenzylglycineandn3hydroxypropylglycineinduceuterinecontractionsexvivoinwaysthatdifferfromthatofoxytocin
AT iizukatakashi twooxytocinanalogsnpfluorobenzylglycineandn3hydroxypropylglycineinduceuterinecontractionsexvivoinwaysthatdifferfromthatofoxytocin
AT hosonotakashi twooxytocinanalogsnpfluorobenzylglycineandn3hydroxypropylglycineinduceuterinecontractionsexvivoinwaysthatdifferfromthatofoxytocin
AT onomasanori twooxytocinanalogsnpfluorobenzylglycineandn3hydroxypropylglycineinduceuterinecontractionsexvivoinwaysthatdifferfromthatofoxytocin
AT fujiwarahiroshi twooxytocinanalogsnpfluorobenzylglycineandn3hydroxypropylglycineinduceuterinecontractionsexvivoinwaysthatdifferfromthatofoxytocin
AT yokoyamashigeru twooxytocinanalogsnpfluorobenzylglycineandn3hydroxypropylglycineinduceuterinecontractionsexvivoinwaysthatdifferfromthatofoxytocin
AT shutosatoshi twooxytocinanalogsnpfluorobenzylglycineandn3hydroxypropylglycineinduceuterinecontractionsexvivoinwaysthatdifferfromthatofoxytocin
AT higashidaharuhiro twooxytocinanalogsnpfluorobenzylglycineandn3hydroxypropylglycineinduceuterinecontractionsexvivoinwaysthatdifferfromthatofoxytocin